We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




World's Largest Medication Error Database Formed

By HospiMedica staff writers
Posted on 20 Dec 2007
Print article
The largest medication error database in the world draws information from more than 400 hospitals and healthcare systems in the United States to help in the identification and prevention of medication errors and adverse drug events.

The MEDMARX U.S. national adverse drug event reporting database was formed by a strategic alliance between the U.S. Pharmacopeia (USP, Rockville, MD, USA) and Quantros (Milpitas, CA, USA), a health care information management technology provider. Under the arrangement, Quantros will manage the operations of the MEDMARX system, including marketing, sales, and client support. This will enable USP to continue its focus on data analysis, research, standards setting, and dissemination of safe practices that will help practitioners prevent errors.

"Quantros' and USP's patient safety efforts are complementary,” said Roger L. Williams, M.D., executive vice president and CEO of USP. "The two organizations share a commitment to reducing medication errors and improving public health. This partnership will provide customers with the best of each organization's strengths--clinical technology management from Quantros, and data analysis, research, standards-setting and reporting from USP.”

"We look forward to providing MEDMARX subscribers with an even more robust database that can reveal to health care providers additional valuable patient safety information,” said Sanjaya Kumar, M.D., president and CEO of Quantros.

MEDMARX is an internet-accessible database that hospitals and health care systems use to track and trend adverse drug reactions and medication errors. Hospitals and health care systems participate in MEDMARX voluntarily and subscribe to it on an annual basis. MEDMARX subscribers can access data from more than 1.1 million adverse drug event records that follow standardized definitions. This allows easy and insightful comparisons to data and solutions from other similar organizations, trend analyses, and the development of best practices to prevent adverse drug events.


Related Links:
U.S. Pharmacopeia
Quantros
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Digital Radiography System
DigiEye 680
New
Automated External Defibrillator
HeartStart OnSite AED

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.